TCL Archive Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020 January 28, 2011
TCL Archive CDC Contribution To National Dialogue Raises Questions About Ties With ACS. September 22, 2000
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing October 10, 1980
